Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Immune Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT05893641
What this trial is testing

Investigate the Relationship Between Exercise Training and Recovery Ratio to Improve Physical Performance and Health Status

Who this might be right for
ExerciseRecovery
Tel Aviv University 200
Large-scale testing (Phase 3)Study completedNCT01126541
What this trial is testing

SMART Study: A Study of Re-treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on Anti-TNF Alfa Therapy

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 224
Early research (Phase 1)Study completedNCT00000899
What this trial is testing

A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Ended earlyNCT01651936
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial to Evaluate the Safety, Tolerability, and Efficacy of MK-8457 in Participants With Rheumatoid Arthritis (MK-8457-010)

Who this might be right for
Rheumatoid Arthritis
Merck Sharp & Dohme LLC 56
Very early researchActive Not RecruitingNCT06959563
What this trial is testing

Early Phase Clinical Trial About Therapeutic Biological Product Mix for Treating HPV

Who this might be right for
HPV Infection
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair 20
Not applicableStudy completedNCT00002385
What this trial is testing

The Safety and Effectiveness of Fozivudine Tidoxil in HIV-1 Infected Patients

Who this might be right for
HIV Infections
Anderson Clinical Research 60
Testing effectiveness (Phase 2)Study completedNCT00999830
What this trial is testing

Evaluation of Activity, Safety and Pharmacology of IPH2101 a Human Monoclonal Antibody in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Innate Pharma 27
Testing effectiveness (Phase 2)Ended earlyNCT05781750
What this trial is testing

Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)

Who this might be right for
Lupus Nephritis
Kezar Life Sciences, Inc. 84
Not applicableStudy completedNCT01610362
What this trial is testing

Human Rabies Immunoglobulin (HRIG)- Dosage Determination and Interference With the Active Immune Response

Who this might be right for
Rabies
Queen Saovabha Memorial Institute 50
Large-scale testing (Phase 3)Study completedNCT02011334
What this trial is testing

A Study Assessing the Safety and Efficacy of Subcutaneous RoActemra/Actemra Alone or in Combination With Non-biologic Antirheumatics in Rhuematoid Arthritis Patients in Latin America With Inadequate Response to Non-biologic Antirheumatic Drugs.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 285
Testing effectiveness (Phase 2)Study completedNCT00012467
What this trial is testing

Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis

Who this might be right for
Meningitis, CryptococcalHIV Infections
InterMune 60
Testing effectiveness (Phase 2)Study completedNCT00913432
What this trial is testing

Masitinib in Combination With Methotrexate, in Treatment of Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
AB Science 20
Testing effectiveness (Phase 2)Study completedNCT02015520
What this trial is testing

Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
CSL Behring 143
Early research (Phase 1)Study completedNCT05581641
What this trial is testing

Safety and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria

Who this might be right for
Malaria
BioNTech SE 60
Not applicableActive Not RecruitingNCT06838780
What this trial is testing

Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundance, Direct LS-TA

Who this might be right for
Gene ExpressionGene Expression ProfilingInfection+3 more
Chinese University of Hong Kong 192
Not applicableStudy completedNCT03173144
What this trial is testing

Chronic Inflammatory Disease, Lifestyle and Treatment Response

Who this might be right for
Autoimmune DiseasesInflammatory Bowel DiseasesCrohn Disease (CD)+7 more
University of Southern Denmark 233
Early research (Phase 1)Study completedNCT01890213
What this trial is testing

Immunotherapy With CEA(6D) VRP Vaccine (AVX701) in Patients With Stage III Colorectal Cancer

Who this might be right for
Stage III Colon Cancer
Duke University 12
Large-scale testing (Phase 3)Study completedNCT02955212
What this trial is testing

A Study With Upadacitinib (ABT-494) in Subjects From China and Selected Countries With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 338
Testing effectiveness (Phase 2)WithdrawnNCT02097264
What this trial is testing

A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biopsies in Subjects With Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Who this might be right for
InflammationRheumatoid Arthritis
Novo Nordisk A/S
Large-scale testing (Phase 3)Study completedNCT01245439
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 65
Next Page